Back to Search
Start Over
NICE rejects Sanofi's Sarclisa in preliminary guidelines
- Source :
- Legal Monitor Worldwide. June 10, 2020
- Publication Year :
- 2020
-
Abstract
- The company proposes that Sarclisa plus pomalidomide and dexamethasone (pom-dex) be used to treat multiple myeloma only in people who have had at least three treatments before. At this stage [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- Legal Monitor Worldwide
- Publication Type :
- News
- Accession number :
- edsgcl.626206033